《亞洲股市》臺股及港股升1%及1.3% 日經逆吐0.8%
美股連續第四天高收漲1%-1.8%,美國包括房價升幅加快等多項經濟數據勝預期,加上俄烏第五輪和平談判取得進展,油價等大宗商價格繼續回落,紓緩市場對通脹加劇影響經濟憂慮,標普11個(能源除外)主要板塊及道指成份股普遍造好,科技股續跑贏,進一步邁向一週七天每日24小時營業目標的網上證券行Robinhood((HOOD.US)更急漲24%,費城半導體指數漲2.2%,帶動納指續彈1.8%,道指及標普續升1%及1.2%四連漲。此外,歐元區主要股市昨晚全面續升2.4%-3.1%,泛歐600續升1.7%,但富時一百僅彈近0.9%。
美股期貨全面微吐不足0.2%。亞太區股市早段普遍向好。然而,美元兌日圓於亞洲續吐近0.5%報122.3,日本2月零售銷售額按年五個月來首降0.8%遜預期,日經繼昨天回升1.1%高收28,252後,今早回落,最低見27,946,現報28,024,回吐227點或0.8%。
臺灣加權指數連彈第二天,報17,728,續升1.1%。南韓(KOSPI)最高見2,760,現報2,749,續升0.3%。澳洲200七連升,報7,528,升近0.9%。新西蘭50指數續彈0.7%報12,003。新加坡海峽指數連升第六天,報3,440,升0.2%。吉隆坡綜合指數繼昨天續吐0.9%後,今早回升0.1%報1,585。
滬指繼昨天回軟後,今早高開0.4%報3,217,最高見3,224,現報3,220,回升0.5%;深成四連跌後,今早高開0.6%報11,969,最高見11,998,現報11,967,回升0.6%。
港股承昨天高收兩連漲勢,今早在全年多賺近12%增派息建行(00939.HK)、騰訊(00700.HK)、阿裏(09988.HK)、藥明生物(02269.HK)、美團(03690.HK)及京東(09618.HK)高開逾1%-2%帶動、恆指高開174點或0.8%報22,101,在科指及地產分類指數升幅擴至1.7%及1.3%帶動,現報22,219即市高位,升幅擴至291點或1.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.